UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 653

Sortiert nach

S5.1 - Proteomics based studies of disease effects on the brain barrier transporters

Drug metabolism and pharmacokinetics, 2020, Vol.35 (1), p.S10-S10

Terasaki, Tetsuya

2020

Link zum Volltext

Verfügbarkeit prüfen

Establishment and validation of highly accurate formalin-fixed paraffin-embedded quantitative proteomics by heat-compatible pressure cycling technology using phase-transfer surfactant and SWATH-MS

Scientific reports, 2020-07, Vol.10 (1), p.11271-11271, Article 11271

2020

Link zum Volltext

Verfügbarkeit prüfen

Quantitative expression of ADME proteins at the blood-brain barrier

Drug metabolism and pharmacokinetics, 2017-01, Vol.32 (1), p.S12-S12

Terasaki, Tetsuya

2017

Link zum Volltext

Verfügbarkeit prüfen

Quantitative targeted absolute proteomics of human blood–brain barrier transporters and receptors

Journal of neurochemistry, 2011-04, Vol.117 (2), p.333-345

2011

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Determination of Luminal and Abluminal Membrane Distributions of Transporters in Porcine Brain Capillaries by Plasma Membrane Fractionation and Quantitative Targeted Proteomics

Journal of pharmaceutical sciences, 2015-09, Vol.104 (9), p.3060-3068

2015

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Atlas of Blood–Brain Barrier Transporters, Receptors, and Tight Junction Proteins in Rats and Common Marmoset

Journal of pharmaceutical sciences, 2013-09, Vol.102 (9), p.3343-3355

2013

Link zum Volltext

Verfügbarkeit prüfen

Selective Protein Expression Changes of Leukocyte-Migration-Associated Cluster of Differentiation Antigens at the Blood–Brain Barrier in a Lipopolysaccharide-Induced Systemic Inflammation Mouse Model without Alteration of Transporters, Receptors or Tight Junction-Related Protein

Biological and Pharmaceutical Bulletin, 2019/06/01, Vol.42(6), pp.944-953

2019

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Targeted Absolute Proteomics-Based Adme Research as A New Path to Drug Discovery and Development: Methodology, Advantages, Strategy, and Prospects

Journal of pharmaceutical sciences, 2011-09, Vol.100 (9), p.3547-3559

2011

Link zum Volltext

Verfügbarkeit prüfen

Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice

The Journal of pharmacology and experimental therapeutics, 2011-11, Vol.339 (2), p.579

2011

Link zum Volltext

Verfügbarkeit prüfen

Identification and Validation of Combination Plasma Biomarker of Afamin, Fibronectin and Sex Hormone-Binding Globulin to Predict Pre-eclampsia

Biological and Pharmaceutical Bulletin, 2021/06/01, Vol.44(6), pp.804-815

2021

Link zum Volltext

Verfügbarkeit prüfen

Activation of Annexin A2 signaling at the blood–brain barrier in a mouse model of multiple sclerosis

Journal of neurochemistry, 2022-03, Vol.160 (6), p.662-674

2022

Link zum Volltext

Verfügbarkeit prüfen

Determination of Intrinsic Creatine Transporter (Slc6a8) Activity and Creatine Transport Function of Leukocytes in Rats

Biological and Pharmaceutical Bulletin, 2020/03/01, Vol.43(3), pp.474-479

2020

Link zum Volltext

Verfügbarkeit prüfen

Major involvement of Na+‐dependent multivitamin transporter (SLC5A6/SMVT) in uptake of biotin and pantothenic acid by human brain capillary endothelial cells

Journal of neurochemistry, 2015-07, Vol.134 (1), p.97-112

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery

Pharmaceutical research, 2022-07, Vol.39 (7), p.1363-1392

2022

Link zum Volltext

Verfügbarkeit prüfen

The blood‐brain barrier fatty acid transport protein 1 (FATP1/SLC27A1) supplies docosahexaenoic acid to the brain, and insulin facilitates transport

Journal of neurochemistry, 2017-05, Vol.141 (3), p.400-412

2017

Link zum Volltext

Verfügbarkeit prüfen

Organic Anion-Transporting Polypeptide 1a4 (Oatp1a4/Slco1a4) at the Blood–Arachnoid Barrier is the Major Pathway of Sulforhodamine-101 Clearance from Cerebrospinal Fluid of Rats

Molecular pharmaceutics, 2019-05, Vol.16 (5), p.2021-2027

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Absolute Protein Abundances of Transporters and Receptors among Blood-Brain Barriers at Different Cerebral Regions and the Blood-Spinal Cord Barrier in Humans and Rats

Molecular pharmaceutics, 2020-06, Vol.17 (6), p.2006-2020

2020

Link zum Volltext

Verfügbarkeit prüfen

Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR‐654‐5p and miR‐450b‐5p

Cancer science, 2020-07, Vol.111 (7), p.2413-2422

2020

Link zum Volltext

Verfügbarkeit prüfen

Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats

Molecular pharmaceutics, 2018-03, Vol.15 (3), p.911-922

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics

PloS one, 2018-03, Vol.13 (3), p.e0193799-e0193799

2018

Link zum Volltext

Verfügbarkeit prüfen

Oxidative stress-induced activation of Abl and Src kinases rapidly induces P-glycoprotein internalization via phosphorylation of caveolin-1 on tyrosine-14, decreasing cortisol efflux at the blood–brain barrier

Journal of cerebral blood flow and metabolism, 2020-02, Vol.40 (2), p.420-436

2020

Link zum Volltext

Verfügbarkeit prüfen

Cluster of Differentiation 46 Is the Major Receptor in Human Blood–Brain Barrier Endothelial Cells for Uptake of Exosomes Derived from Brain-Metastatic Melanoma Cells (SK-Mel-28)

Molecular pharmaceutics, 2019-01, Vol.16 (1), p.292-304

2019

Link zum Volltext

Verfügbarkeit prüfen

Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes

Drug metabolism and disposition, 2020-02, Vol.48 (2), p.135-145

2020

Link zum Volltext

Verfügbarkeit prüfen

A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood-brain barrier in ddY, FVB, and C57BL/6J mice

Fluids and barriers of the CNS, 2013-06, Vol.10 (1), p.21-21, Article 21

2013

Link zum Volltext

Verfügbarkeit prüfen

Actin filament‐associated protein 1 (AFAP‐1) is a key mediator in inflammatory signaling‐induced rapid attenuation of intrinsic P‐gp function in human brain capillary endothelial cells

Journal of neurochemistry, 2017-04, Vol.141 (2), p.247-262

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 653

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(533)
Mit Volltextzugriff
(598)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(365)
Life Sciences & Biomedicine
(337)
Animals
(260)
Male
(190)
Pharmacology & Pharmacy
(174)
Rats
(162)
Biological And Medical Sciences
(159)
Humans
(137)
Blood-Brain Barrier
(128)
Medical Sciences
(108)
Pharmacology. Drug Treatments
(81)
Mice
(77)
Rats, Wistar
(71)
Physical Sciences
(70)
Brain - Metabolism
(68)
Pharmaceutical Science
(68)
Chemistry
(67)
Neurosciences
(67)
Neurosciences & Neurology
(66)
Fundamental And Applied Biological Sciences. Psychology
(64)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

S5.1 - Proteomics based studies of disease effects on the brain barrier transporters

Establishment and validation of highly accurate formalin-fixed paraffin-embedded quantitative proteomics by heat-compatible pressure cycling technology using phase-transfer surfactant and SWATH-MS

Quantitative expression of ADME proteins at the blood-brain barrier

Quantitative targeted absolute proteomics of human blood–brain barrier transporters and receptors

Quantitative Determination of Luminal and Abluminal Membrane Distributions of Transporters in Porcine Brain Capillaries by Plasma Membrane Fractionation and Quantitative Targeted Proteomics

Quantitative Atlas of Blood–Brain Barrier Transporters, Receptors, and Tight Junction Proteins in Rats and Common Marmoset

Selective Protein Expression Changes of Leukocyte-Migration-Associated Cluster of Differentiation Antigens at the Blood–Brain Barrier in a Lipopolysaccharide-Induced Systemic Inflammation Mouse Model without Alteration of Transporters, Receptors or Tight Junction-Related Protein

Quantitative Targeted Absolute Proteomics-Based Adme Research as A New Path to Drug Discovery and Development: Methodology, Advantages, Strategy, and Prospects

Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice

Identification and Validation of Combination Plasma Biomarker of Afamin, Fibronectin and Sex Hormone-Binding Globulin to Predict Pre-eclampsia

Activation of Annexin A2 signaling at the blood–brain barrier in a mouse model of multiple sclerosis

Determination of Intrinsic Creatine Transporter (Slc6a8) Activity and Creatine Transport Function of Leukocytes in Rats

Major involvement of Na+‐dependent multivitamin transporter (SLC5A6/SMVT) in uptake of biotin and pantothenic acid by human brain capillary endothelial cells

Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery

The blood‐brain barrier fatty acid transport protein 1 (FATP1/SLC27A1) supplies docosahexaenoic acid to the brain, and insulin facilitates transport

Organic Anion-Transporting Polypeptide 1a4 (Oatp1a4/Slco1a4) at the Blood–Arachnoid Barrier is the Major Pathway of Sulforhodamine-101 Clearance from Cerebrospinal Fluid of Rats

Comparison of Absolute Protein Abundances of Transporters and Receptors among Blood-Brain Barriers at Different Cerebral Regions and the Blood-Spinal Cord Barrier in Humans and Rats

Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR‐654‐5p and miR‐450b‐5p

Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats

Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics

Oxidative stress-induced activation of Abl and Src kinases rapidly induces P-glycoprotein internalization via phosphorylation of caveolin-1 on tyrosine-14, decreasing cortisol efflux at the blood–brain barrier

Cluster of Differentiation 46 Is the Major Receptor in Human Blood–Brain Barrier Endothelial Cells for Uptake of Exosomes Derived from Brain-Metastatic Melanoma Cells (SK-Mel-28)

Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes

A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood-brain barrier in ddY, FVB, and C57BL/6J mice

Actin filament‐associated protein 1 (AFAP‐1) is a key mediator in inflammatory signaling‐induced rapid attenuation of intrinsic P‐gp function in human brain capillary endothelial cells

Suchergebnisse filtern